Early versus late dexamethasone treatment in preterm infants at risk for chronic lung disease: a randomized pilot study

1999 ◽  
Vol 158 (4) ◽  
pp. 318-322 ◽  
Author(s):  
U. Merz ◽  
T. Peschgens ◽  
G. Kusenbach ◽  
H. Hörnchen
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
Lung Disease ◽  
Preterm Infants ◽  
Chronic Lung Disease ◽  
Dexamethasone Treatment

Effect on Growth of Two Different Dexamethasone Courses for Preterm Infants at Risk of Chronic Lung Disease

Pharmacology ◽  
1999 ◽  
Vol 59 (5) ◽  
pp. 266-274 ◽  
Author(s):  
Costantino Romagnoli ◽  
Enrico Zecca ◽  
Giovanni Vento ◽  
Luca Maggio ◽  
Patrizia Papacci ◽  
...  
Keyword(s):  
At Risk ◽  
Lung Disease ◽  
Preterm Infants ◽  
Chronic Lung Disease ◽  
Effect On Growth

The role of ASC signalling in preterm infants at risk of chronic lung disease of prematurity

2018 ◽  
Author(s):  
David Gallacher ◽  
Martha Triantafilou ◽  
Julian Marchesi ◽  
Kathy Trianafilou ◽  
Sailesh Kotecha
Keyword(s):  
At Risk ◽  
Lung Disease ◽  
Preterm Infants ◽  
Chronic Lung Disease

Controlled Trial of Early Dexamethasone Treatment for the Prevention of Chronic Lung Disease in Preterm Infants: A 3-Year Follow-up

PEDIATRICS ◽  
2002 ◽  
Vol 109 (6) ◽  
pp. e85-e85 ◽  
Author(s):  
C. Romagnoli ◽  
E. Zecca ◽  
R. Luciano ◽  
G. Torrioli ◽  
G. Tortorolo
Keyword(s):  
Lung Disease ◽  
Preterm Infants ◽  
Chronic Lung Disease ◽  
Controlled Trial ◽  
Dexamethasone Treatment

Treating Preterm Infants at Risk for Chronic Lung Disease with Dexamethasone Leads to an Impaired Quality of General Movements

Neonatology ◽  
2002 ◽  
Vol 82 (3) ◽  
pp. 155-158 ◽  
Author(s):  
Arend F. Bos ◽  
Jasmin Dibiasi ◽  
Ansje H. Tiessen ◽  
Klasien A. Bergman
Keyword(s):  
At Risk ◽  
Lung Disease ◽  
Preterm Infants ◽  
Chronic Lung Disease ◽  
General Movements ◽  
Impaired Quality
Sign in / Sign up

Export Citation Format

Share Document